Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Community sentiment
Where do you think TRAX is heading?
Keep private notes on TRAX — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
TRAX vs S&P 500 · rebased to 100
Background shading marks the US business-cycle phase at each point in time — early, mid and late expansion, then recession— so you can see which economic backdrop each move happened in. Recessions are NBER-official; expansion sub-phases are ActaClear's editorial dating.
Live market
as of Jun 29, 2026- Market cap
- $560.7M
- Enterprise value
- $312.3M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- 2.18×
- Dividend yield
- 0.0%
- 52-wk high
- $25.58
- 52-wk low
- $14.79
- Beta
- —
- Shares out
- 34.9M
What this company does
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited combined financial statements and related notes for the three months ended March 31, 2026, included in Part I, Item 1 of this Quarterly Report and with our audited combined financial statements and related notes thereto for the year ended December 31, 2025 included in our Form 10 filed with the Securities and Exchange Commission on March 27, 2026. This discussion and other sections of this Quarterly Report contain forward-looking statements that involve risks…
AI summary unavailable — showing raw filing excerpt
Generated from TRAX's filing dated 2026-05-14
Key risks
Item 1A. Risk Factors. Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other information in this Quarterly Report, including our combined financial statements and the related notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” before deciding whether to invest in our common stock. The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations, and growth prospects. In such an event, the market price of our common stock could decline, and you may lose all or part of your investment.…
AI summary unavailable — showing raw filing excerpt
Generated from TRAX's filing dated 2026-05-14
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Pharmaceutical Preparations (531 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 28, 2026.